QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.051995v1 307/1/223    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Quilley, J. Articles by Hirt, J. Search for Related Content PubMed PubMed Citation Articles by Quilley, J. Articles by Hirt, J.

CARDIOVASCULAR

Inhibitors of 20-Hydroxyeicosatetraenoic Acid Reduce Renal Vasoconstrictor Responsiveness

Department of Pharmacology, New York Medical College, Valhalla, New York

20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P450-derived constrictor eicosanoid produced by the preglomerular vasculature where it contributes to regulation of tone. Removal of the tonic inhibitory influence of nitric oxide (NO) has been reported to increase renal 20-HETE release. Because inhibition of NO synthesis enhances responses to vasoconstrictor agents, we examined a contribution for increased 20-HETE generation. In the rat kidney perfused with Krebs' buffer, responses to U46619 (9,11-dideoxy-9,11-methanoepoxy PGF₂), a thromboxane A₂ mimetic, were compared before and after 50 µM L-nitroarginine (L-NA) to inhibit NO synthase. L-NA raised perfusion pressure (PP) from 79 ± 3 to 190 ± 7 mm Hg and enhanced constrictor responsiveness to U46619. U46619 (10, 30, 100, and 300 ng) increased PP by 7 ± 1, 17 ± 2, 50 ± 7, and 67 ± 7 mm Hg, respectively, before L-NA and 15 ± 1, 37 ± 7, 68 ± 10, and 85 ± 11 mm Hg, respectively, after L-NA, which did not increase 20-HETE efflux from the kidney. Nonetheless, an inhibitor of -hydroxylase, dibromododecencyl methylsulfonimide (DDMS), which reduced 20-HETE release, normalized the enhanced responsiveness to U46619. When PP was elevated with phenylephrine, vasoconstrictor responses to U46619 were similarly enhanced, an effect that was also prevented by DDMS. DDMS and an antagonist of 20-HETE, 20-HEDE [20-hydroxyeicosa-6(Z), 15(Z)-dienoic acid], also reduced vasoconstrictor responses to U46619 in the absence of elevation of PP. Because 20-HETE inhibits K⁺ channels, we examined the effects of K⁺ channel inhibitors on vasoconstrictor responses and showed that both tetraethylammonium (TEA) and charybdotoxin enhanced renal vasoconstrictor responses to U46619. However, the inhibitory effects of 20-HEDE on vasoconstrictor responses remained after treatment with TEA. These results support a role for 20-HETE vasoconstrictor responses but suggest an action independent of K⁺ channels.

Address correspondence to: Dr. J. Quilley, Department of Pharmacology, New York Medical College, Valhalla, NY 10595. E-mail: john_quilley{at}nymc.edu

This article has been cited by other articles:

				A. D. Baines and P. Ho 20-HETE-mediated vasoconstriction by hemoglobin-O2 carrier in Sprague-Dawley but not Wistar rats J Appl Physiol, March 1, 2005; 98(3): 772 - 779. [Abstract] [Full Text] [PDF]

				S. M. Hamza and S. Kaufman A vibrator prevents streaming during close-arterial infusion into the kidney Am J Physiol Renal Physiol, April 1, 2004; 286(4): F643 - F646. [Abstract] [Full Text] [PDF]